Fu Y - Search Results

1

Characterization of FGF401 as a reversible covalent inhibitor of fibroblast growth factor receptor 4.

Zhou Z , Chen X , Fu Y , Zhang Y , Dai S , Li J , Chen L , Xu G , Chen Z , Chen Y . Zhou Z , et al. Among authors: fu y. Chem Commun (Camb). 2019 May 21;55(42):5890-5893. doi: 10.1039/c9cc02052g. Chem Commun (Camb). 2019. PMID: 31041948

2

Proteomic Characterization Reveals a Molecular Portrait of Nasopharyngeal Carcinoma Differentiation.

Xiao Z, Li M, Li G, Fu Y, Peng F, Chen Y, Chen Z. Xiao Z, et al. Among authors: fu y. J Cancer. 2017 Feb 11;8(4):570-577. doi: 10.7150/jca.17414. eCollection 2017. J Cancer. 2017. PMID: 28367237 Free PMC article.

3

Quantitative proteomic profiling of tumor-associated vascular endothelial cells in colorectal cancer.

Wang G, Yang Q, Li M, Zhang Y, Cai Y, Liang X, Fu Y, Xiao Z, Zhou M, Xie Z, Huang H, Huang Y, Chen Y, He Q, Peng F, Chen Z. Wang G, et al. Among authors: fu y. Biol Open. 2019 May 13;8(5):bio042838. doi: 10.1242/bio.042838. Biol Open. 2019. PMID: 31036754 Free PMC article.

4

A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.

Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, Fu Y, Guo M, Huang H, Ou Y, Chen Y. Feng Y, et al. Among authors: fu y. Cell Death Dis. 2020 Feb 3;11(2):89. doi: 10.1038/s41419-020-2278-6. Cell Death Dis. 2020. PMID: 32015333 Free PMC article.

5

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer.

Huang H, Liu R, Huang Y, Feng Y, Fu Y, Chen L, Chen Z, Cai Y, Zhang Y, Chen Y. Huang H, et al. Among authors: fu y. Aging (Albany NY). 2020 Jul 17;12(14):14699-14717. doi: 10.18632/aging.103530. Epub 2020 Jul 17. Aging (Albany NY). 2020. PMID: 32678070 Free PMC article.

6

Computational repositioning of dimethyl fumarate for treating alcoholic liver disease.

Zhang Y, Zhao S, Fu Y, Yan L, Feng Y, Chen Y, Wu Y, Deng Y, Zhang G, Chen Z, Chen Y, Liu T. Zhang Y, et al. Among authors: fu y. Cell Death Dis. 2020 Aug 18;11(8):641. doi: 10.1038/s41419-020-02890-3. Cell Death Dis. 2020. PMID: 32811823 Free PMC article.

7

Development of a Potent and Specific FGFR4 Inhibitor for the Treatment of Hepatocellular Carcinoma.

Rezende Miranda R, Fu Y, Chen X, Perino J, Cao P, Carpten J, Chen Y, Zhang C. Rezende Miranda R, et al. Among authors: fu y. J Med Chem. 2020 Oct 22;63(20):11484-11497. doi: 10.1021/acs.jmedchem.0c00044. Epub 2020 Oct 8. J Med Chem. 2020. PMID: 33030342

8

Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics.

Huang H, Fu Y, Zhang Y, Peng F, Lu M, Feng Y, Chen L, Chen Z, Li M, Chen Y. Huang H, et al. Among authors: fu y. Front Cell Dev Biol. 2020 Nov 26;8:577784. doi: 10.3389/fcell.2020.577784. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33324635 Free PMC article.

9

Learning important features from multi-view data to predict drug side effects.

Liang X, Zhang P, Li J, Fu Y, Qu L, Chen Y, Chen Z. Liang X, et al. Among authors: fu y. J Cheminform. 2019 Dec 16;11(1):79. doi: 10.1186/s13321-019-0402-3. J Cheminform. 2019. PMID: 33430979 Free PMC article.

10

Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4.

Shao M, Chen X, Yang F, Song X, Zhou Y, Lin Q, Fu Y, Ortega R, Lin X, Tu Z, Patterson AV, Smaill JB, Chen Y, Lu X. Shao M, et al. Among authors: fu y. J Med Chem. 2022 Mar 24;65(6):5113-5133. doi: 10.1021/acs.jmedchem.2c00096. Epub 2022 Mar 10. J Med Chem. 2022. PMID: 35271262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,358 results

Search Page

Filters